Manvir Victor’s Post

It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.

The KDIGO 2024 CKD Guidebline Executive Summary.

The KDIGO 2024 CKD Guidelines are here! This is a major update to the 2012 guidelines which have guided CKD management for many years. Great job KDIGO on synthesizing the latest evidence to guide nephrologists in CKD care!

🌟 Exciting News in Kidney Disease Management! 🌟 📚 Just Released: A Comprehensive Guidance Document on Chronic Kidney Disease (CKD) Management 🔍 Multinational population studies based on CKD-PC 2023 analyses highlight the incremental increase in the association of all CKD complications with worse categories of estimated glomerular filtration rate (eGFR) and albuminuria. 💡 Key Highlights: -Emphasis on the importance of detecting CKD early, especially in high-risk populations. -Recommendations for accurate assessment of GFR and urine albumin-to-creatinine ratio (ACR). -Importance of using validated risk equations to estimate absolute risk of kidney failure. -Comprehensive discussion on delaying CKD progression and managing complications. -Insights into cardiovascular risk factor modification and drug stewardship in CKD. -Optimal models of care, including the value of multidisciplinary teams and advanced care planning. 🔬 Newer data on treating hyperuricemia were evaluated, with no support for targeting hyperuricemia in the absence of symptoms. 📊 Tables provided for "expected" values for common laboratory tests by eGFR to aid in identifying aberrant values. 🚀 Conclusion: This guidance document offers exciting new approaches to CKD management, aiming to improve symptom management, disease modification, and person-centered care. #KidneyDisease #CKDManagement #Healthcare #MedicalResearch #PatientCare #HealthTech #Nephrology #ChronicDiseaseManagement

Mycetoma occurs in multiple countries across the ‘mycetoma belt’, which stretches across five continents between the latitudes of 15° S and 30° N. The fungal version of #mycetoma, known as eumycetoma, can cause severe deformities, disability, and mental health issues due to the stigma associated with the chronic, unrelenting course of the disease and lack of effective treatment, which often leads to amputation. Join us in this webinar with Drugs for Neglected Diseases initiative - DNDi and Centers for Disease Control and Prevention during Fungal Disease Awareness Week as we bring together healthcare experts and advocates to discuss diagnosis, treatment, and research progress. Register here: https://bit.ly/3AVs2I5 #FungalWeek24

#Hyperphagia, an insatiable hunger, is more than just an appetite—it's a challenge faced by individuals with rare #MC4R pathway diseases, often leading to severe obesity from an early age. Raising awareness is the first step toward understanding and supporting individuals living with these challenges. Together, we can bring cures closer to #MENAT patients. #RaisingAwareness #MC4RPathway

May is CIDP Awareness Month – chronic inflammatory demyelinating polyneuropathy (CIDP) is a debilitating condition that affects the nerves, leading to muscle weakness. Diagnosis can be challenging, often taking months or even years, further delaying effective treatment and disease management. We remain committed to addressing the unmet needs of those living with #CIDP and helping to spread awareness and education. #GBSCIDPAwarenessMonth #CIDPAwarenessMonth #PlasmaDerivedTherapies #Plasma #RareDisease #CIDP

🌍 More than 10 million people worldwide live with inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, according to the Crohn's & Colitis Foundation. Many individuals living with these conditions may navigate physical, psychological, and social challenges December 1-7 marks Crohn's and Colitis Awareness Week, an opportunity to spotlight these challenges and to stand in solidarity with patients, families, and caregivers. This week, let’s come together to increase awareness of IBD, encourage early diagnosis, and advocate for continuous research and innovative therapies that can transform lives. #AlfasigmaHealthHub #PharmaceuticalsWithPassion #CCAwarenessWeek #IBDAwareness

Raise awareness this Rheumatological Diseases Awareness Month. Know the symptoms, share knowledge, and support those affected. #RheumAwareness #FightRheumatology #RheumatologicalDiseases #KnowTheSigns #AsterBangalore #AsterHospitals

Every step counts in the fight against autoimmune blistering diseases! 🌟 From enlightening talks and personal stories to interactive sessions and heartfelt connections, we came together to spread knowledge about autoimmune blistering diseases and to support one another in this journey. 💬 Your presence and involvement mean the world to us and bring us one step closer to a future where no one has to face these challenges alone. 🌍🤝 Let's continue to raise awareness, advocate for better treatments, and support each other with strength and compassion. 💪💜 Visit www.aibdf.in for more information! 🌐 #aibdf #autoimmuneblisteringdiseases #autoimmunedisorder #blister #autoimmunelife #autoimmunewarriors #discussion #autoimmunewarrior #autoimmunedisease #autoimmunediseaseawareness #autoimmunecondition #supportgroup #autoimmunehealth #autoimmunedisorders #autoimmunediseases #autoimmuneawareness #blisters #autoimmuneillness #patientcare #autoimmunefighter